Opioid agonist treatment scale-up and the initiation of injection drug use: A dynamic modeling analysis.
Charles MarksAnnick BorquezSonia JainXiaoying SunSteffanie A StrathdeeRichard S GarfeinMichael John MilloyKora DeBeckJavier A CepedaDaniel WerbNatasha K MartinPublished in: PLoS medicine (2019)
In addition to its known benefits on preventing HIV, hepatitis C virus (HCV), and overdose among PWID, our modeling suggests that OAT scale-up may also reduce the number of IDU initiations and PWID population size.